{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:02:16Z","timestamp":1790096536812,"version":"4.0.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jaci.2018.03.023","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T11:33:56Z","timestamp":1528803236000},"page":"1087-1099.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Induction of bystander tolerance and immune deviation after Fel d 1 peptide immunotherapy"],"prefix":"10.1016","volume":"143","author":[{"given":"Daniel M.","family":"Moldaver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mantej S.","family":"Bharhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Rudulier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Wattie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Inman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Larch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2018.03.023_bib1","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1398-9995.2005.00781.x","article-title":"Longitudinal study on the relationship between cat allergen and endotoxin exposure, sensitization, cat-specific IgG and development of asthma in childhood\u2014report of the German Multicentre Allergy Study (MAS 90)","volume":"60","author":"Lau","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.03.023_bib2","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/S0140-6736(00)02842-7","article-title":"Early exposure to house-dust mite and cat allergens and development of childhood asthma: a cohort study","volume":"356","author":"Lau","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2018.03.023_bib3","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jaci.2007.07.056","article-title":"Asthma cases attributable to atopy: results from the Third National Health and Nutrition Examination Survey","volume":"120","author":"Arbes","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1056\/NEJM198902023200502","article-title":"Association of asthma with serum IgE levels and skin-test reactivity to allergens","volume":"320","author":"Burrows","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2018.03.023_bib5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1056\/NEJM199201303260504","article-title":"Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma","volume":"326","author":"Robinson","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2018.03.023_bib6","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.4049\/jimmunol.148.8.2390","article-title":"Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte\/macrophage-colony-stimulating factor in the nasal mucosa after local allergen\u00a0provocation: relationship to tissue eosinophilia","volume":"148","author":"Durham","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib7","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.20032058","article-title":"Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells","volume":"199","author":"Akdis","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.03.023_bib8","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jaci.2007.02.023","article-title":"Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma","volume":"119","author":"Hartl","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib9","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0140-6736(04)15592-X","article-title":"Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease","volume":"363","author":"Ling","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2018.03.023_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1398-9995.2007.01526.x","article-title":"The functional insufficiency of human CD4+CD25high T-regulatory cells in allergic asthma is subjected to TNF-\u03b1 modulation","volume":"63","author":"Lin","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.03.023_bib11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2007.01451.x","article-title":"Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study","volume":"62","author":"Jacobsen","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.03.023_bib12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0091-6749(97)70069-1","article-title":"Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children","volume":"99","author":"Des Roches","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib13","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1046\/j.1365-2222.2001.01161.x","article-title":"Prevention of new\u00a0sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A\u00a0six-year follow-up study","volume":"31","author":"Pajno","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2018.03.023_bib14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199908123410702","article-title":"Long-term clinical efficacy of grass-pollen immunotherapy","volume":"341","author":"Durham","year":"1999","journal-title":"N Engl J Med"},{"issue":"suppl","key":"10.1016\/j.jaci.2018.03.023_bib15","doi-asserted-by":"crossref","first-page":"S306","DOI":"10.1016\/j.jaci.2009.10.064","article-title":"Allergen immunotherapy","volume":"125","author":"Frew","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jaci.2012.07.028","article-title":"Fel\u00a0d\u00a01-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study","volume":"131","author":"Patel","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib17","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/cea.12488","article-title":"Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects","volume":"45","author":"Couroux","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2018.03.023_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaci.2010.11.029","article-title":"Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy","volume":"127","author":"Worm","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl","key":"10.1016\/j.jaci.2018.03.023_bib19","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1038\/nm1226","article-title":"Peptide-based therapeutic vaccines for allergic and autoimmune diseases","volume":"11","author":"Larche","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2018.03.023_bib20","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1398-9995.2011.02610.x","article-title":"Immunotherapy with peptides","volume":"66","author":"Moldaver","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.03.023_bib21","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/eji.1830130809","article-title":"Haplotype-specific suppressor T cells mediating linked suppression of immune responses elicited by third-party H-2 alloantigens","volume":"13","author":"Holan","year":"1983","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib22","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1084\/jem.20082901","article-title":"Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression","volume":"206","author":"Campbell","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.03.023_bib23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0952-7915(98)80217-3","article-title":"Infectious tolerance","volume":"10","author":"Cobbold","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/mi.2013.56","article-title":"Amelioration of OVA-induced allergic airway disease following Der p 1 peptide immunotherapy is not associated with induction of IL-35","volume":"7","author":"Moldaver","year":"2013","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib25","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/intimm\/5.9.1159","article-title":"Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity","volume":"5","author":"Metzler","year":"1993","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1164\/rccm.200305-690OC","article-title":"Late asthmatic reactions induced by inhalation of allergen-derived T cell peptides","volume":"169","author":"Ali","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2018.03.023_bib27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1242\/dmm.001859","article-title":"Concurrent dual allergen exposure and its effects on airway hyperresponsiveness, inflammation and remodeling in mice","volume":"2","author":"DiGiovanni","year":"2009","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jaci.2018.03.023_bib28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1465-9921-7-120","article-title":"Regional differences in the pattern of airway\u00a0remodeling following chronic allergen exposure in mice","volume":"7","author":"Hirota","year":"2006","journal-title":"Respir Res"},{"key":"10.1016\/j.jaci.2018.03.023_bib29","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/glycob\/cwi097","article-title":"Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand","volume":"15","author":"Tateno","year":"2005","journal-title":"Glycobiology"},{"key":"10.1016\/j.jaci.2018.03.023_bib30","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1398-9995.2004.00601.x","article-title":"Cat allergen peptide immunotherapy reduces CD4(+) T cell responses to cat allergen but does not alter suppression by CD4(+) CD25(+) T cells: a double-blind placebo-controlled study","volume":"59","author":"Smith","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.03.023_bib31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0091-6749(98)70294-5","article-title":"Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats","volume":"102","author":"P\u00e8ne","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib32","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0091-6749(98)70402-6","article-title":"Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom","volume":"101","author":"M\u00fcller","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0140-6736(02)09332-7","article-title":"Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a\u00a0randomised controlled trial","volume":"360","author":"Oldfield","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2018.03.023_bib34","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.4049\/jimmunol.167.3.1734","article-title":"Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects","volume":"167","author":"Oldfield","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib35","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2222.2006.02469.x","article-title":"Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy","volume":"36","author":"Tarzi","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2018.03.023_bib36","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1371\/journal.pmed.0020078","article-title":"T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity","volume":"2","author":"Verhoef","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.jaci.2018.03.023_bib37","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1073\/pnas.95.12.6930","article-title":"T1\/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function","volume":"95","author":"L\u00f6hning","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2018.03.023_bib38","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1084\/jem.190.7.895","article-title":"Crucial role of the interleukin 1 receptor family member T1\/St2 in T helper cell type 2\u2013mediated lung mucosal immune responses","volume":"190","author":"Coyle","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.03.023_bib39","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1164\/rccm.200805-666OC","article-title":"Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1\/ST2\u2013IL-33 pathway","volume":"179","author":"Kearley","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2018.03.023_bib40","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jaci.2018.03.023_bib41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.it.2007.10.004","article-title":"The 'short' history of regulatory B cells","volume":"29","author":"Mauri","year":"2008","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib42","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jaci.2010.01.018","article-title":"Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model","volume":"125","author":"Amu","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2249.2001.01602.x","article-title":"Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-\u03b3, IL-4, IL-10 and IL-13) in patients with allergic asthma","volume":"125","author":"Wong","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib44","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1067\/mai.2003.1557","article-title":"Airway remodeling-associated mediators in moderate to severe asthma: Effect of steroids on TGF-\u03b2, IL-11, IL-17, and type I and type III collagen expression","volume":"111","author":"Chakir","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib45","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nm.1968","article-title":"Prostaglandin E2-EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion","volume":"15","author":"Yao","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2018.03.023_bib46","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaci.2016.11.043","article-title":"Treatment with grass allergen peptides improves symptoms of grass pollen-induced allergic rhinoconjunctivitis","volume":"140","author":"Ellis","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib47","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/pai.12092","article-title":"Considering 25 years of research on allergy prevention\u2014have we let ourselves down?","volume":"24","author":"Wahn","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib48","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1084\/jem.178.5.1783","article-title":"Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice","volume":"178","author":"Hoyne","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.03.023_bib49","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.4049\/jimmunol.170.3.1240","article-title":"Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in\u00a0vivo","volume":"170","author":"Sundstedt","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib50","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0091-6749(99)70232-0","article-title":"Immunotherapy in children with allergic asthma: effect on bronchial hyperreactivity and pharmacotherapy","volume":"103","author":"Hedlin","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib51","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJM199010113231505","article-title":"Eosinophilic inflammation in asthma","volume":"323","author":"Bousquet","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2018.03.023_bib52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaci.2014.12.1938","article-title":"Prevention of allergic asthma through Der p 2 peptide vaccination","volume":"136","author":"Bouchaud","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib53","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jaci.2015.04.018","article-title":"Single allergen-induced oral tolerance inhibits airway inflammation in conjugated allergen immunized mice","volume":"136","author":"Chien","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib54","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1084\/jem.20110767","article-title":"Sustained suppression by Foxp3+ regulatory T cells is vital for infectious transplantation tolerance","volume":"208","author":"Kendal","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.03.023_bib55","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jaci.2013.01.014","article-title":"IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses","volume":"131","author":"van de Veen","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib56","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jaci.2007.06.013","article-title":"Sublingual immunotherapy induces IL-10\u2013producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation","volume":"120","author":"Bohle","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.023_bib57","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7520605","article-title":"Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis","volume":"265","author":"Chen","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jaci.2018.03.023_bib58","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/376177a0","article-title":"Peripheral deletion of antigen-reactive T cells in oral tolerance","volume":"376","author":"Chen","year":"1995","journal-title":"Nature"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918308510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918308510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:19:26Z","timestamp":1758791966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674918308510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0091674918308510"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2018.03.023","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of bystander tolerance and immune deviation after Fel d 1 peptide immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2018.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}